Literature DB >> 6406594

High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.

H M Moutsopoulos, A D Steinberg, A S Fauci, H C Lane, N M Papadopoulos.   

Abstract

Sjogren's syndrome presents a wide spectrum of disease manifestations ranging from benign to malignant lymphoproliferation. Sera from 21 patients with primary Sjogren's syndrome, 63 patients with other autoimmune rheumatic diseases, and 140 normal controls were studied by using high-resolution gel electrophoresis combined with immunofixation and specific absorption studies. Two-thirds of the sera from Sjogren's syndrome patients contained free monoclonal lambda light chains. In addition, one patient with Sjogren's syndrome and pseudolymphoma had a circulating monoclonal IgM-lambda immunoglobulin. In contrast, only 16% of the patients with other autoimmune diseases and 5% of normals had monoclonal bands; none of the other patients studied exhibited monoclonal-free lambda light chains in their serum. Our findings suggest that the monoclonal process in Sjogren's syndrome starts early in the disease process in a subset of B cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406594

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Renal tubular acidosis in primary Sjögren's syndrome.

Authors:  K C Siamopoulos; M Elisaf; A A Drosos; A A Mavridis; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

Review 2.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 3.  A conspicuous role for B cells In Sjögren's syndrome.

Authors:  Pierre Youinou; Valérie Devauchelle; Pascal Hutin; Rozenn Le Berre; Alain Saraux; Jacques-Olivier Pers
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

4.  Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A Fox; B R Smith
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

5.  Urinary monoclonal free light chains in primary Sjögren's syndrome: an aid to the diagnosis of malignant lymphoma.

Authors:  M T Walters; F K Stevenson; A Herbert; M I Cawley; J L Smith
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

6.  Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.

Authors:  J-E Gottenberg; F Aucouturier; J Goetz; C Sordet; I Jahn; M Busson; J-M Cayuela; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

7.  Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome.

Authors:  H M Moutsopoulos; R Costello; A A Drosos; A K Mavridis; N M Papadopoulos
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

8.  Monoclonal process in primary Sjögren's syndrome and cross-reactive idiotype associated with rheumatoid factor.

Authors:  P D Katsikis; P Y Youinou; V Galanopoulou; N M Papadopoulos; A G Tzioufas; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 9.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

10.  Activation of peripheral blood lymphocytes in patients with primary Sjögren's syndrome.

Authors:  P Youinou; Y L Pennec; M A Blaschek; A Gentric; J Jouquan; A Lamour; P Angelidis
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.